Science for a better future - R&D

about ADMIR

Key Feature

12 patents

Secrete knowhow

3M€ R&D funding

about research

Today R&D

As the James Webb telescope uses the infrared spectroscopic technology to reveal the chemical composition of distant and huge objects of our universe, the ADMIR microscope exploits the same principles to provide bio-chemical mapping of tiny objects of the living world. Our researches have led to a drastic reduction of the analysis time down to one minute per image instead of hours with conventional systems. These technological breakthroughs have been achieved inside our former R&D team that has an international recognition in the field of spectroscopic sensors in the mid-infrared (Mix@d-IR) range. High-brightness, highly monochromatic quantum cascade (QCL) MIR lasers have in particular been studied (Fedeli & al, 2018) (Coutard & al, 2020). ADMIR also relies on more than 20 years of development of infrared imagers based on bolometer arrays (Yon & al, 2014). ADMIR has been built around these core competences.

From now on, the medical practitioners can use this Mid-IR spectroscopic analysis, which was so far reserved for the research world. In particular, ADMIR offers powerful analysis tool for tissues, cells, bacteria colonies or yeasts.

our technology


Research and Development
Research and Development
Research and Development

our technology


Wavenumber (in cm-1)
Research and Development
Enterobacter cloacae
Research and Development
Escherichia coli
Research and Development
Staphylococcus epidermidis

Microbial colonies such as presented above are acquired with the ADMIR system at nine different wavenumbers. Computer vision and machine learning processes then allow to classify the optical fingerprints. This process correctly identify up to 94% of colonies. Current works focus on improving reliability, expanding the number of target species, as well as developping new tools and algorithms dedicated to strain-typing.


our futurE

What’s next

At mid-term, ADMIR has the ambition of providing an efficient diagnosis tool for cancers (lung, breast, prostate…) and infectious diseases or for any analyses in pharma or biotech. In long term, ADMIR intends to offer a small enough system to be used inside an endoscope removing the necessity to have a biopsy. This opens a new route toward a fast and weakly invasive tissue analysis.

Interested in this Technology ?